课题基金 / 基金详情

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
BALANCE：针对革兰氏阴性血流感染的平台试验
批准号：
466451
负责人：
Daneman Nick
金额：
$212.71万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-07-01 至 2025-07-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466451&lang=en
关键词：
Adaptive Platform Trial Antibiotic De-Escalation Antibiotic Step-Down Antimicrobial Resistance Bloodstream Infection Central Venous Catheter Infection Gram Negative Bacteremia Randomized Controlled Trial

项目摘要

项目成果

Daneman Nick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bloodstream infections are a leading cause of death in Canada and worldwide, yet remain understudied, such that we do not know the best treatment strategies to be sure to cure the infection while minimizing harms of excess antibiotics causing antimicrobia
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficient Facility Feedback of Existing Culture Testing is Able to Mitigate Resistance (EFFECT-AMR)
  • 批准号：
    478247
  • 项目类别：
    Operating Grants
  • 资助金额：
    $49.88万
  • 财政年份：
    2023
  • 负责人：
    Daneman Nick
  • 依托单位：
    Public Health Ontario (Toronto)
Evaluating the impact of a SIMPlified LaYered consent process versus a conventional informed consent form on recruitment of potential participants to a large platform clinical trial: a pragmatic nested randomized controlled trial (SIMPLY-SNAP Trial) - Ful
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial
海外基金